aluates Reports

$ 0.0

Automative

Global RDC (Radionuclide Drug Conjugate) Services Market Research Report 2026

Published Date: 2026-01-29

Report Code: QYRE-Auto-33G18300

Global RDC Radionuclide Drug Conjugate Services Market Research Report 2024

BUY CHAPTERS

Global RDC (Radionuclide Drug Conjugate) Services Market Research Report 2026

Code: QYRE-Auto-33G18300

Report

2026-01-29

Pages:92

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abzena

WuXi XDC

CD Formulation

CPC Scientific Inc.

Rdcthera

RDC (Radionuclide Drug Conjugate) Services Market

The global RDC (Radionuclide Drug Conjugate) Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

RDC (Radionuclide Drug Conjugate) services refer to professional services provided for the development, production and application of radionuclide drug conjugates. These conjugates usually combine radioisotopes with drugs (such as monoclonal antibodies, peptides or small molecules) to target specific cells or tissues for treatment, especially in cancer treatment. The main contents of RDC services include drug development, radionuclide labeling and screening, preclinical research (evaluation of drug conjugates), etc.

The North American market for RDC (Radionuclide Drug Conjugate) Services is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for RDC (Radionuclide Drug Conjugate) Services is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for RDC (Radionuclide Drug Conjugate) Services in Pharmaceutical Companies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of RDC (Radionuclide Drug Conjugate) Services include Rdcthera, Abzena, WuXi XDC, CD Formulation, CPC Scientific Inc, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global RDC (Radionuclide Drug Conjugate) Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding RDC (Radionuclide Drug Conjugate) Services. The RDC (Radionuclide Drug Conjugate) Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global RDC (Radionuclide Drug Conjugate) Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist RDC (Radionuclide Drug Conjugate) Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of RDC (Radionuclide Drug Conjugate) Services Market Report

Report Metric	Details
Report Name	RDC (Radionuclide Drug Conjugate) Services Market
Segment by Type	Antibody Radionuclide Conjugates (ARC) Peptide Radionuclide Conjugates (PRC) Small Molecular Radionuclide Conjugates (SMRC)
Segment by Application	Pharmaceutical Companies Medical Device Companies Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Rdcthera, Abzena, WuXi XDC, CD Formulation, CPC Scientific Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for RDC (Radionuclide Drug Conjugate) Services companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the RDC (Radionuclide Drug Conjugate) Services Market report?

Ans: The main players in the RDC (Radionuclide Drug Conjugate) Services Market are Rdcthera, Abzena, WuXi XDC, CD Formulation, CPC Scientific Inc

What are the Application segmentation covered in the RDC (Radionuclide Drug Conjugate) Services Market report?

Ans: The Applications covered in the RDC (Radionuclide Drug Conjugate) Services Market report are Pharmaceutical Companies, Medical Device Companies, Other

What are the Type segmentation covered in the RDC (Radionuclide Drug Conjugate) Services Market report?

Ans: The Types covered in the RDC (Radionuclide Drug Conjugate) Services Market report are Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Antibody Radionuclide Conjugates (ARC)

1.2.3 Peptide Radionuclide Conjugates (PRC)

1.2.4 Small Molecular Radionuclide Conjugates (SMRC)

1.3 Market by Application

1.3.1 Global RDC (Radionuclide Drug Conjugate) Services Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Pharmaceutical Companies

1.3.3 Medical Device Companies

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global RDC (Radionuclide Drug Conjugate) Services Market Perspective (2021–2032)

2.2 Global RDC (Radionuclide Drug Conjugate) Services Growth Trends by Region

2.2.1 Global RDC (Radionuclide Drug Conjugate) Services Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 RDC (Radionuclide Drug Conjugate) Services Historic Market Size by Region (2021–2026)

2.2.3 RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Region (2027–2032)

2.3 RDC (Radionuclide Drug Conjugate) Services Market Dynamics

2.3.1 RDC (Radionuclide Drug Conjugate) Services Industry Trends

2.3.2 RDC (Radionuclide Drug Conjugate) Services Market Drivers

2.3.3 RDC (Radionuclide Drug Conjugate) Services Market Challenges

2.3.4 RDC (Radionuclide Drug Conjugate) Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top RDC (Radionuclide Drug Conjugate) Services Players by Revenue

3.1.1 Global Top RDC (Radionuclide Drug Conjugate) Services Players by Revenue (2021–2026)

3.1.2 Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Players (2021–2026)

3.2 Global Top RDC (Radionuclide Drug Conjugate) Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by RDC (Radionuclide Drug Conjugate) Services Revenue

3.4 Global RDC (Radionuclide Drug Conjugate) Services Market Concentration Ratio

3.4.1 Global RDC (Radionuclide Drug Conjugate) Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by RDC (Radionuclide Drug Conjugate) Services Revenue in 2025

3.5 Global Key Players of RDC (Radionuclide Drug Conjugate) Services Head Offices and Areas Served

3.6 Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Products and Applications

3.7 Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 RDC (Radionuclide Drug Conjugate) Services Breakdown Data by Type

4.1 Global RDC (Radionuclide Drug Conjugate) Services Historic Market Size by Type (2021–2026)

4.2 Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Type (2027–2032)

5 RDC (Radionuclide Drug Conjugate) Services Breakdown Data by Application

5.1 Global RDC (Radionuclide Drug Conjugate) Services Historic Market Size by Application (2021–2026)

5.2 Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America RDC (Radionuclide Drug Conjugate) Services Market Size (2021–2032)

6.2 North America RDC (Radionuclide Drug Conjugate) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2021–2026)

6.4 North America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe RDC (Radionuclide Drug Conjugate) Services Market Size (2021–2032)

7.2 Europe RDC (Radionuclide Drug Conjugate) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2021–2026)

7.4 Europe RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size (2021–2032)

8.2 Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size by Region (2021–2026)

8.4 Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America RDC (Radionuclide Drug Conjugate) Services Market Size (2021–2032)

9.2 Latin America RDC (Radionuclide Drug Conjugate) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2021–2026)

9.4 Latin America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size (2021–2032)

10.2 Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2021–2026)

10.4 Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Rdcthera

11.1.1 Rdcthera Company Details

11.1.2 Rdcthera Business Overview

11.1.3 Rdcthera RDC (Radionuclide Drug Conjugate) Services Introduction

11.1.4 Rdcthera Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)

11.1.5 Rdcthera Recent Development

11.2 Abzena

11.2.1 Abzena Company Details

11.2.2 Abzena Business Overview

11.2.3 Abzena RDC (Radionuclide Drug Conjugate) Services Introduction

11.2.4 Abzena Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)

11.2.5 Abzena Recent Development

11.3 WuXi XDC

11.3.1 WuXi XDC Company Details

11.3.2 WuXi XDC Business Overview

11.3.3 WuXi XDC RDC (Radionuclide Drug Conjugate) Services Introduction

11.3.4 WuXi XDC Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)

11.3.5 WuXi XDC Recent Development

11.4 CD Formulation

11.4.1 CD Formulation Company Details

11.4.2 CD Formulation Business Overview

11.4.3 CD Formulation RDC (Radionuclide Drug Conjugate) Services Introduction

11.4.4 CD Formulation Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)

11.4.5 CD Formulation Recent Development

11.5 CPC Scientific Inc

11.5.1 CPC Scientific Inc Company Details

11.5.2 CPC Scientific Inc Business Overview

11.5.3 CPC Scientific Inc RDC (Radionuclide Drug Conjugate) Services Introduction

11.5.4 CPC Scientific Inc Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)

11.5.5 CPC Scientific Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abzena

WuXi XDC

CD Formulation

CPC Scientific Inc.

Rdcthera

List of Tables

Table 1. Global RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Antibody Radionuclide Conjugates (ARC)

Table 3. Key Players of Peptide Radionuclide Conjugates (PRC)

Table 4. Key Players of Small Molecular Radionuclide Conjugates (SMRC)

Table 5. Global RDC (Radionuclide Drug Conjugate) Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Region (US$ Million), 2021–2026

Table 8. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Region (2021–2026)

Table 9. Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Region (2027–2032)

Table 11. RDC (Radionuclide Drug Conjugate) Services Market Trends

Table 12. RDC (Radionuclide Drug Conjugate) Services Market Drivers

Table 13. RDC (Radionuclide Drug Conjugate) Services Market Challenges

Table 14. RDC (Radionuclide Drug Conjugate) Services Market Restraints

Table 15. Global RDC (Radionuclide Drug Conjugate) Services Revenue by Players (US$ Million), 2021–2026

Table 16. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Players (2021–2026)

Table 17. Global Top RDC (Radionuclide Drug Conjugate) Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on RDC (Radionuclide Drug Conjugate) Services Revenue, 2025

Table 18. Ranking of Global Top RDC (Radionuclide Drug Conjugate) Services Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by RDC (Radionuclide Drug Conjugate) Services Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Headquarters and Area Served

Table 21. Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Products and Applications

Table 22. Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Type (US$ Million), 2021–2026

Table 25. Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Type (2021–2026)

Table 26. Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Type (2027–2032)

Table 28. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Application (US$ Million), 2021–2026

Table 29. Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Application (2021–2026)

Table 30. Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Application (2027–2032)

Table 32. North America RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (US$ Million), 2021–2026

Table 34. North America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (US$ Million), 2027–2032

Table 35. Europe RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe RDC (Radionuclide Drug Conjugate) Services Market Size by Country (US$ Million), 2021–2026

Table 37. Europe RDC (Radionuclide Drug Conjugate) Services Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size by Country (US$ Million), 2027–2032

Table 47. Rdcthera Company Details

Table 48. Rdcthera Business Overview

Table 49. Rdcthera RDC (Radionuclide Drug Conjugate) Services Product

Table 50. Rdcthera Revenue in RDC (Radionuclide Drug Conjugate) Services Business (US$ Million), 2021–2026

Table 51. Rdcthera Recent Development

Table 52. Abzena Company Details

Table 53. Abzena Business Overview

Table 54. Abzena RDC (Radionuclide Drug Conjugate) Services Product

Table 55. Abzena Revenue in RDC (Radionuclide Drug Conjugate) Services Business (US$ Million), 2021–2026

Table 56. Abzena Recent Development

Table 57. WuXi XDC Company Details

Table 58. WuXi XDC Business Overview

Table 59. WuXi XDC RDC (Radionuclide Drug Conjugate) Services Product

Table 60. WuXi XDC Revenue in RDC (Radionuclide Drug Conjugate) Services Business (US$ Million), 2021–2026

Table 61. WuXi XDC Recent Development

Table 62. CD Formulation Company Details

Table 63. CD Formulation Business Overview

Table 64. CD Formulation RDC (Radionuclide Drug Conjugate) Services Product

Table 65. CD Formulation Revenue in RDC (Radionuclide Drug Conjugate) Services Business (US$ Million), 2021–2026

Table 66. CD Formulation Recent Development

Table 67. CPC Scientific Inc Company Details

Table 68. CPC Scientific Inc Business Overview

Table 69. CPC Scientific Inc RDC (Radionuclide Drug Conjugate) Services Product

Table 70. CPC Scientific Inc Revenue in RDC (Radionuclide Drug Conjugate) Services Business (US$ Million), 2021–2026

Table 71. CPC Scientific Inc Recent Development

Table 72. Research Programs/Design for This Report

Table 73. Key Data Information from Secondary Sources

Table 74. Key Data Information from Primary Sources

Table 75. Authors List of This Report

List of Figures

Figure 1. RDC (Radionuclide Drug Conjugate) Services Picture

Figure 2. Global RDC (Radionuclide Drug Conjugate) Services Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Type: 2025 vs 2032

Figure 4. Antibody Radionuclide Conjugates (ARC) Features

Figure 5. Peptide Radionuclide Conjugates (PRC) Features

Figure 6. Small Molecular Radionuclide Conjugates (SMRC) Features

Figure 7. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Application (US$ Million), 2021–2032

Figure 8. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Application: 2025 vs 2032

Figure 9. Pharmaceutical Companies Case Studies

Figure 10. Medical Device Companies Case Studies

Figure 11. Other Case Studies

Figure 12. RDC (Radionuclide Drug Conjugate) Services Report Years Considered

Figure 13. Global RDC (Radionuclide Drug Conjugate) Services Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global RDC (Radionuclide Drug Conjugate) Services Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Region: 2025 vs 2032

Figure 16. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Players in 2025

Figure 17. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by RDC (Radionuclide Drug Conjugate) Services Revenue in 2025

Figure 19. North America RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America RDC (Radionuclide Drug Conjugate) Services Market Share by Country (2021–2032)

Figure 21. United States RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe RDC (Radionuclide Drug Conjugate) Services Market Share by Country (2021–2032)

Figure 25. Germany RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Share by Region (2021–2032)

Figure 33. China RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America RDC (Radionuclide Drug Conjugate) Services Market Share by Country (2021–2032)

Figure 41. Mexico RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Share by Country (2021–2032)

Figure 45. Israel RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Rdcthera Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)

Figure 49. Abzena Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)

Figure 50. WuXi XDC Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)

Figure 51. CD Formulation Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)

Figure 52. CPC Scientific Inc Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2021–2026)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Antibody radionuclide Conjugates Market Research Report 2024

Global Radiolabeling Services Market Research Report 2024

Global Targeted SSTR Radionuclide Drug Conjugates Market Research Report 2024

Global Nuclear Medicine Radiopharmaceuticals Market Research Report 2024

Global Radiopharmaceutical Market Research Report 2025

Global Radiopharmaceutical Therapy Market Research Report 2025

Global Nuclear Medicine Market Research Report 2025

Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025

Global Radioisotopes Labeling Services Market Research Report 2024

Global Targeted Radiotherapy Drug Market Research Report 2024

Global SPECT and PET Radiopharmaceuticals Market Research Report 2024

Global Custom Synthesis and Radiolabeling Market Research Report 2024

Global Targeted Radiopharmaceuticals Market Research Report 2024

Radiology Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Conjugates Service Market Research Report 2024

Diagnostic Nuclear Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted PSMA Radionuclide Drug Conjugates Market Research Report 2024

Global Targeted Radionuclide Therapy Market Research Report 2024

Global Peptide Drug Conjugates PDCs CDMO Service Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions